Clinical Trials · NCT06657209
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Stanford University
- Enrollment
- 104
- Start date
- Jan 2025
- Locations
- 2 sites, United States
- Primary endpoint
- Insulin resistance in normal weight women with diabetes compared to those with no diabetes